Search

everythinglearnresearchcommunity

for

Search:↓

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A woman with lupus had blood cell destruction, treated successfully with medication.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Using Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells together can improve healing, including wound healing, bone regeneration, and hair growth.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

PRP helps skin regeneration but needs standardized testing for consistent results.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Low dose methotrexate does not increase hair fall and may reduce it.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Systemic corticosteroids can cause unusual skin issues in people with juvenile rheumatoid arthritis.